BioSpace News Archive

Forecast to 2030,’ thoroughly examines the Peripheral Neuropathy Treatment industry to provide essential data & information for the targeted readers. The report consists of quantitative and qualitative research on the market performed by our market experts. The Peripheral Neuropathy Treatment industry report emphasizes the current and upcoming market revenue growth opportunities and trends

Forecast to 2030,’ thoroughly examines the Post-Surgical Pain Treatment industry to provide essential data & information for the targeted readers

Natera, Inc. announced that Steve Chapman, chief executive officer, and Mike Brophy, chief financial officer, will be presenting at the following upcoming investor conferences.

According to Latest Report Study, the Digital Health market size is expected to be worth around US$ 300.4 billion by 2030 from valued at US$ 96.9 billion in 2020 and is anticipated to grow at a CAGR of 15.5% during forecast period 2021 to 2030.

The global Life Science Analytics market size is expected to be worth around US$ 23.2 billion by 2030, according to a new report by Vision Research Reports.

According to Latest Report, the global Regulatory Affairs Outsourcing market was estimated at US$ 6.6 billion in 2020 and it is expected to surpass around US$ 12.9 billion by 2030 and is anticipated to grow at a CAGR of 8.5% during forecast period 2021 to 2030.

The global sterility indicators market is predicted to experience a strong demand during the forecast period (2021-2031), owing to rapid advancement in the healthcare sector particularly in the emerging countries.

NANOBIOTIX announced that Laurent Levy, Co-Founder and Chief Executive Officer of Nanobiotix, has been named to the PharmaVoice 100 list of the most inspiring people in the life sciences.

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an overview of the Company at the hybrid H.C. Wainwright 24th Annual Global Investment Conference, which will be held September 12-14, 2022.

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (“AcelRx”), today announced that Chief Executive Officer, Vince Angotti will present in-person and be available for one-on-one meetings throughout the H.C. Wainwright Annual Investment Conference.